Treatment and prevention of thrombosis using an anti-miR
AssigneeThomas Jefferson University
InventorsSteven E. McKenzie, Yuhang Zhou, Shaji Abraham
Life of this patent
Estimating the term…
Abstract
Disclosed are anti-miR compositions and methods of use of the same for treatment of or reducing the occurrence of thrombosis and thrombosis related diseases and disorders by reducing platelet activation.
Claims18
A method for reducing platelet activation comprising administering to a patient in need thereof an effective amount of an anti-miR having a corresponding miR having a binding site on TULA-2, wherein the binding of the anti-miR upregulates TULA-2 to mediate platelet activation in the body.
A method for treating thrombosis comprising administering to a subject in need thereof, an effective amount of an anti-miR capable of upregulating the level of a TULA-2 protein that is a negative regulator of platelet activation.
Dependencies are inferred from the claim text.